Data / Research funding / Pediatric - AIDS
Pediatric - AIDS: 304 NIH awards ($1.1B) to 111 organizations
304 NIH awards ($1.1B) in the NIH spending category Pediatric - AIDS, to 111 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
304 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| SDMC: HIV Vaccine Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $156,744,802 | June 29, 2006 | November 30, 2027 | GILBERT, PETER B. | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| Pediatric HIV/AIDS Cohort Study (PHACS) 2020 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $71,153,847 | September 18, 2020 | July 31, 2026 | WILLIAMS, PAIGE L | reporter.nih.gov |
| SDMC - IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $59,233,299 | June 29, 2006 | November 30, 2027 | SHAPIRO, DAVID ERIC | reporter.nih.gov |
| International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,605,531 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,840,939 | May 1, 2025 | April 30, 2027 | ROHNER, ELIANE | reporter.nih.gov |
| Central Africa International Epidemiology databases to Evaluate AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,957,495 | May 1, 2025 | April 30, 2027 | YOTEBIENG, MARCEL | reporter.nih.gov |
| IeDEA Asia-Pacific Research Collaboration | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,360,741 | July 15, 2006 | April 30, 2027 | SOHN, ANNETTE H | reporter.nih.gov |
| Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $9,956,619 | September 25, 2020 | June 30, 2026 | ABRAMS, ELAINE JANINE | reporter.nih.gov |
| Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $9,584,357 | September 30, 2025 | September 29, 2026 | SILVERA, PETER | reporter.nih.gov |
| Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,011,446 | March 9, 2021 | February 28, 2027 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| International Epidemiology Databases to EvaluateAIDS (IeDEA) Renewal 4 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,392,710 | July 1, 2006 | July 2, 2026 | JAQUET, ANTOINE | reporter.nih.gov |
| Pediatric Scientist Development Program | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $7,708,555 | December 1, 1986 | June 30, 2028 | PERMAR, SALLIE R. | reporter.nih.gov |
| Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $6,635,347 | September 18, 2025 | August 31, 2030 | JOHN-STEWART, GRACE C. | reporter.nih.gov |
| Harnessing the power of text messaging to reduce HIV incidence in adolescent males across the United States | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $6,477,724 | September 23, 2021 | December 8, 2027 | YBARRA, MICHELE L. | reporter.nih.gov |
| Effectiveness of Relationship Education for Reducing HIV Incidence in Men Who Have Sex with Men | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,366,745 | April 1, 2021 | March 21, 2025 | NEWCOMB, MICHAEL E | reporter.nih.gov |
| A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,096,179 | September 5, 2023 | June 30, 2028 | SHAPIRO, ROGER L | reporter.nih.gov |
| Optimizing HIV prevention for high-risk methamphetamine-using men who have sex with men | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,855,396 | April 8, 2022 | April 30, 2027 | GROV, CHRISTIAN | reporter.nih.gov |
| Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,559,114 | June 17, 2020 | January 31, 2027 | WALZL, GERHARD | reporter.nih.gov |
| A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,339,746 | February 20, 2018 | January 31, 2026 | SHAPIRO, ROGER L | reporter.nih.gov |
| Clinical Trial Site Monitoring for PHOENIx MDR-TB | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,653,435 | April 15, 2025 | December 14, 2025 | SMITH, KIMBERLY | reporter.nih.gov |
| Rapid disease progression and viral reservoir formation in SIV-infected infant macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,447,199 | June 15, 2021 | May 31, 2026 | SODORA, DONALD L | reporter.nih.gov |
| LA HIV Treatment in Pediatrics | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $4,291,265 | March 15, 2020 | February 28, 2025 | JOHNSON, LEAH | reporter.nih.gov |
| Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,251,563 | February 1, 2018 | February 28, 2026 | ROBB, MERLIN L | reporter.nih.gov |
| Childhood Omics and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $4,076,080 | April 22, 2020 | August 31, 2025 | CATTAMANCHI, ADITHYA | reporter.nih.gov |
| NextGen Long-acting and targeted combination ART for Children with HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,058,459 | April 6, 2020 | March 31, 2027 | HO, RODNEY J.Y. | reporter.nih.gov |
| Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $3,967,474 | September 20, 2022 | August 31, 2027 | NEILAN, ANNE | reporter.nih.gov |
| Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,899,337 | June 1, 2021 | May 31, 2027 | SHIVAKOTI, RUPAK | reporter.nih.gov |
| Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,898,240 | September 8, 2023 | January 5, 2029 | GAROFALO, ROBERT | reporter.nih.gov |
| Making women's options for HIV prevention in Tanzania accessible and joining implementation science capacity building (MWOTAJI) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,724,768 | September 18, 2023 | August 31, 2028 | ANASEL, MACKFALLEN GILIADI | reporter.nih.gov |
| HIV/ART, low birth weight, and mortality in HIV-exposed uninfected children: a translational mechanistic study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,646,054 | April 15, 2021 | March 31, 2027 | YOTEBIENG, MARCEL | reporter.nih.gov |
| Quantification of HIV burden and the biomedical, structural, and behavioral factors influencing HIV/AIDS among children and young adolescents | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,642,543 | March 5, 2021 | March 31, 2026 | KYU, HMWE HMWE | reporter.nih.gov |
| Cannabis use, PrEP and HIV transmission risk | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,624,329 | August 1, 2021 | May 31, 2027 | DUNCAN, DUSTIN T | reporter.nih.gov |
| Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,564,109 | April 9, 2021 | January 31, 2027 | MCHENRY, MEGAN SONG | reporter.nih.gov |
| Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,561,650 | September 1, 2023 | June 30, 2028 | CHARURAT, MANHATTAN E | reporter.nih.gov |
| Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,529,091 | January 24, 2024 | August 31, 2028 | IWELUNMOR, JULIET | reporter.nih.gov |
| Defining adaptive immune responses to Mtb-infection and TB disease among young children with and without HIV-exposure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,527,794 | April 15, 2021 | March 31, 2027 | LANCIONI, CHRISTINA LOUISE | reporter.nih.gov |
| Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,525,168 | January 7, 2020 | December 31, 2025 | KLAUSNER, JEFFREY DAVID | reporter.nih.gov |
| Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,515,485 | September 19, 2022 | July 31, 2027 | SAGAR, MANISH | reporter.nih.gov |
| Optimizing evidence-based HIV prevention targeting people who inject drugs on PrEP | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,386,037 | September 1, 2022 | June 30, 2027 | COPENHAVER, MICHAEL | reporter.nih.gov |
| M. tuberculosis exosome detection for pediatric TB diagnosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,323,600 | June 1, 2025 | May 31, 2027 | LACOURSE, SYLVIA | reporter.nih.gov |
| Enhancing PrEP outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,313,701 | September 22, 2021 | August 31, 2026 | PINTYE, JILLIAN | reporter.nih.gov |
| Goals for Adherence with Low-cost Incentives (GOALS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,250,180 | May 17, 2021 | January 31, 2027 | LINNEMAYR, SEBASTIAN | reporter.nih.gov |
| Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,247,236 | September 1, 2021 | August 31, 2025 | PERMAR, SALLIE R. | reporter.nih.gov |
| Keeping it LITE 2: Exploring HIV Risk in Vulnerable Youth with Limited Interaction and Digital Health Intervention (LITE-2) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,236,862 | May 19, 2022 | July 31, 2027 | HOSEK, SYBIL | reporter.nih.gov |
| PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,235,332 | April 1, 2023 | March 31, 2028 | CATTAMANCHI, ADITHYA | reporter.nih.gov |
| Suubi+Adherence-R2: Examining the longitudinal HIV treatment adherence among youth living with HIV (YLHIV) transitioning into young adulthood | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,232,155 | September 30, 2012 | July 31, 2025 | SSEWAMALA, FRED M | reporter.nih.gov |
| Biomarker Signatures of TB Infection in Young Children With and Without HIV | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,173,148 | April 28, 2023 | March 31, 2028 | SALGAME, PADMINI | reporter.nih.gov |
| Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,139,781 | May 6, 2020 | April 30, 2026 | BRYSON, BRYAN DAVID | reporter.nih.gov |
| Influence of maternal virome and HIV status on infant gut virome, growth and immunity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,044,222 | September 21, 2020 | August 31, 2025 | JASPAN, HEATHER BERYL | reporter.nih.gov |
| Pediatric HIV reservoir determinants and consequences | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $3,036,579 | September 30, 1987 | April 30, 2027 | JOHN-STEWART, GRACE C. | reporter.nih.gov |
| The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,016,481 | March 21, 2022 | February 28, 2027 | FUNDERBURG, NICHOLAS T. | reporter.nih.gov |
| Regional Prospective Observational Research in Tuberculosis (RePORT) – Brazil Network | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,000,000 | January 2, 2023 | December 31, 2027 | STERLING, TIMOTHY R | reporter.nih.gov |
| Optimizing PrEP regimens for pregnant women in sub-Saharan Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,978,273 | April 13, 2021 | March 31, 2027 | CHI, BENJAMIN H. | reporter.nih.gov |
| Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM | NIH | National Institute of Mental Health | 2021 to 2024 | $2,966,971 | April 16, 2020 | March 31, 2025 | SULLIVAN, PATRICK SEAN | reporter.nih.gov |
| Cannabis, HIV and Mental Processing Systems (CHAMPS) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,959,350 | August 1, 2021 | May 31, 2027 | ANCES, BEAU M | reporter.nih.gov |
| PHASES Adolescence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,953,055 | August 1, 2015 | July 31, 2025 | LYERLY, ANNE DRAPKIN | reporter.nih.gov |
| How sound processing in the ear and brain relates to educational outcomes, mental health, and quality of life in adolescents living with HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,943,990 | August 16, 2018 | May 31, 2029 | BUCKEY, JAY C | reporter.nih.gov |
| MAPs for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric HIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,906,725 | March 16, 2020 | March 31, 2026 | CHOY, ROBERT KWAI MING | reporter.nih.gov |
| Implementation Science to Understand and Design Stakeholder Informed Innovative Interventions to Improve Adolescent and Youth HIV Prevention and Care Continuums in Rural and Urban Uganda | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,890,646 | September 8, 2023 | August 31, 2028 | MUSOKE, PHILIPPA | reporter.nih.gov |
| Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,856,384 | June 1, 2022 | April 30, 2027 | JASPAN, HEATHER BERYL | reporter.nih.gov |
| Adolescent health behaviors in the time of COVID-19 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,852,328 | August 20, 2021 | June 30, 2026 | YBARRA, MICHELE L. | reporter.nih.gov |
| Leveraging HIV infrastructure to implement cervical cancer prevention in adolescent HIV clinics in Zambia | NIH | National Cancer Institute | 2022 to 2025 | $2,769,417 | September 6, 2022 | August 31, 2027 | HUNLETH, JEAN MARIE | reporter.nih.gov |
| ZAIMARA: Zambian Informed Motivated Aware and Responsible Adolescents and Adults | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,766,583 | September 12, 2023 | August 31, 2028 | BOLTON MOORE, CAROLYN | reporter.nih.gov |
| Neurocognitive development of HIV-exposed and uninfected infants in Malawi | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,678,523 | August 1, 2020 | May 31, 2026 | LAUFER, MIRIAM K. | reporter.nih.gov |
| Pragmatic Efficacy Trial of mHealth to Improve HIV Outcomes in the DC Cohort | NIH | National Institute of Mental Health | 2021 to 2024 | $2,631,350 | July 20, 2020 | June 30, 2026 | CASTEL, AMANDA DERRYCK | reporter.nih.gov |
| HEU outcomes: population-evaluation and screening strategies (HOPE) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $2,621,605 | August 7, 2020 | June 30, 2026 | JOHN-STEWART, GRACE C. | reporter.nih.gov |
| Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,561,391 | May 1, 2021 | April 30, 2029 | BIRBECK, GRETCHEN L. | reporter.nih.gov |
| Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,508,444 | August 3, 2020 | July 31, 2025 | NAIDOO, ANUSHKA | reporter.nih.gov |
| Adolescent Wellness Visits in Tanzania | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,505,226 | February 1, 2024 | January 31, 2025 | BAUMGARTNER, JOY NOEL | reporter.nih.gov |
| Disclosure Intervention to Support Caregivers (DISC) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $2,504,560 | August 17, 2020 | December 31, 2025 | POWIS, KATHLEEN | reporter.nih.gov |
| Novel and Optimized Diagnostics for Pediatric TB | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $2,451,069 | May 7, 2020 | April 30, 2026 | ELLNER, JERROLD J. | reporter.nih.gov |
| Family Connections cluster RCT in Zambia: Impact of a youth and caregiver intervention on virologic status among HIV-positive youth (ages 15-21) | NIH | National Institute of Mental Health | 2021 to 2024 | $2,445,411 | September 1, 2020 | August 31, 2025 | DENISON, JULIE ANNE | reporter.nih.gov |
| Integrating PrEP delivery in family planning clinics in Kenya | NIH | National Institute of Mental Health | 2021 to 2024 | $2,443,757 | May 1, 2020 | April 30, 2025 | MUGWANYA, KENNETH KIGGUNDU | reporter.nih.gov |
| Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,440,431 | May 1, 2025 | April 30, 2028 | SEDDON, JAMES ALEXANDER | reporter.nih.gov |
| The Role of Inflammation in CNS Mechanisms of Anhedonia and Psychomotor Slowing in Depressed PWH as Determined using a Next Generation TNF Antagonist | NIH | National Institute of Mental Health | 2021 to 2025 | $2,439,698 | September 10, 2021 | August 31, 2027 | FELGER, JENNIFER C | reporter.nih.gov |
| Screen Smart: Using Digital Health to Improve HIV Screening and Prevention for Adolescents in the Emergency Department | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,438,058 | April 13, 2023 | March 31, 2028 | REED, JENNIFER LYNN | reporter.nih.gov |
| Long-term neurocognitive outcomes of HIV-exposed uninfected children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $2,434,267 | July 17, 2022 | June 30, 2026 | LAUFER, MIRIAM K. | reporter.nih.gov |
| Optimizing PrEP implementation and effectiveness among women at high risk for HIV acquisition in South Africa | NIH | National Institute of Mental Health | 2021 to 2024 | $2,426,401 | August 14, 2020 | July 31, 2025 | SCHWARTZ, SHEREE RENAE | reporter.nih.gov |
| Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,404,290 | July 20, 2023 | June 30, 2028 | SCANGA, CHARLES A. | reporter.nih.gov |
| Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,396,349 | May 11, 2023 | January 31, 2028 | BEBELL, LISA M | reporter.nih.gov |
| “Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies. | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,383,968 | December 15, 2011 | January 31, 2028 | GANDHI, MONICA | reporter.nih.gov |
| Moon and Sun Brothers: A group-based Prevention Intervention | NIH | National Institute of Mental Health | 2025 | $2,320,682 | September 20, 2023 | July 31, 2028 | SANCHEZ-VAZNAUGH, EMMA V. | reporter.nih.gov |
| Early prevention interventions towards ART-free pediatric HIV remission | NIH | National Institute of Mental Health | 2023 to 2025 | $2,307,267 | February 16, 2023 | January 31, 2028 | XU, HUANBIN | reporter.nih.gov |
| Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia | NIH | National Cancer Institute | 2023 to 2025 | $2,294,758 | September 1, 2023 | August 31, 2027 | SUBRAMANIAN, SUJHA | reporter.nih.gov |
| Rakai Orphans in Communities | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,244,181 | September 21, 2023 | May 31, 2028 | SANTELLI, JOHN S. | reporter.nih.gov |
| Role of bFGF low affinity receptors in childhood HIVAN | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,237,272 | September 1, 1999 | June 30, 2027 | RAY, PATRICIO E. | reporter.nih.gov |
| Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,131,407 | June 17, 2022 | May 31, 2027 | GOULDER, PHILIP J | reporter.nih.gov |
| Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,079,336 | June 27, 2019 | May 31, 2025 | KANTOR, RAMI | reporter.nih.gov |
| Multilevel strategies to understand and modify the role of structural and environmental context on HIV inequities for sexual and gender minorities of color | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,068,431 | March 18, 2022 | April 30, 2027 | RENDINA, H. JONATHON | reporter.nih.gov |
| Reaching for the end of pediatric AIDS: Modeling strategies to strengthen the maternal-child HIV care continuum and eliminate vertical HIV transmission. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $2,050,215 | July 1, 2014 | April 30, 2029 | CIARANELLO, ANDREA LYNNE | reporter.nih.gov |
| Multilevel strategies to understand and modify the role of structural and environmental factors in HIV outcomes (LITE-2) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,997,143 | March 18, 2022 | April 30, 2027 | TAGGART, TAMARA | reporter.nih.gov |
| Network Canvas 2.0: Enhancing network data capture for drug use and HIV research | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,983,981 | April 1, 2023 | January 31, 2028 | BIRKETT, MICHELLE | reporter.nih.gov |
| Bridges2Scale: Testing implementation strategies for an intervention among young people affected by AIDS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,944,964 | August 23, 2023 | August 2, 2025 | SSEWAMALA, FRED M | reporter.nih.gov |
| NICHD BIOSPECIMEN REPOSITORY SERVICES FOR LEGACY COLLECTION | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $1,928,620 | September 16, 2025 | September 15, 2026 | MARTIN, BRITTANY | reporter.nih.gov |
| HPV, HIV and Oral Microbiota Interplay in Nigerian Youth (HOMINY) | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $1,910,616 | August 1, 2024 | July 31, 2027 | COKER, MODUPE | reporter.nih.gov |
| Suubi4HER Round 2: Examining the Long-term Impact of A Combination Intervention on HIV Prevention, Care and Mental Health for Adolescents and Young Women in Uganda | NIH | National Institute of Mental Health | 2021 to 2025 | $1,904,111 | August 1, 2017 | March 31, 2029 | SSEWAMALA, FRED M | reporter.nih.gov |
| Harnessing the power of technology to develop a population-based HIV prevention program for trans girls | NIH | National Institute of Nursing Research | 2021 to 2024 | $1,872,429 | September 8, 2021 | June 30, 2025 | YBARRA, MICHELE L. | reporter.nih.gov |
| Evaluating a Multilevel Communication Campaign to Increase HIV Vaccine Trial Enrollment | NIH | National Institute of Mental Health | 2023 to 2025 | $1,828,286 | May 19, 2023 | April 1, 2025 | ANDRASIK, MICHELE PEAKE | reporter.nih.gov |
| Neural correlates of in utero HIV and ART exposure: early childhood follow-up of a prospectively recruited cohort | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,819,763 | September 22, 2023 | May 31, 2028 | VAN DER KOUWE, ANDRE JAN WILLEM | reporter.nih.gov |
| Increased risk of STI and HIV among adolescent girls and young women due to COVID-19 and pandemic mitigation: Biological, behavioral, and psychosocial mediators | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,810,346 | September 19, 2021 | June 30, 2025 | MEHTA, SUPRIYA DINESH | reporter.nih.gov |
| Mwanza-Tanzania Research Training Program in HIV Clinical Investigation | NIH | Fogarty International Center | 2021 to 2025 | $1,808,742 | April 1, 2021 | March 31, 2027 | FITZGERALD, DANIEL W | reporter.nih.gov |
| Optimizing HIV-malaria treatment in a shifting treatment and resistance landscape in Africa | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,796,782 | December 23, 2010 | June 30, 2029 | PARIKH, SUNIL | reporter.nih.gov |
| Early life determinants of cardiometabolic health from birth to adolescence amongst HIV-exposed and unexposed South African children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,751,931 | August 18, 2022 | July 31, 2027 | PELLOWSKI, JENNIFER ANN | reporter.nih.gov |
| Immune correlates of LTBI in HIV-exposed infants | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,724,753 | January 5, 2019 | December 31, 2025 | PAHWA, SAVITA | reporter.nih.gov |
| Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,696,966 | May 1, 2023 | April 30, 2028 | KHAN, MANSOOR A | reporter.nih.gov |
| Understanding ischemia in children with tuberculous meningitis (iThemba) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,692,676 | August 1, 2022 | May 31, 2027 | SEDDON, JAMES ALEXANDER | reporter.nih.gov |
| Siyakhula: Growing HIV/TB Research Knowledge for Growing Healthy Kids in Eswatini | NIH | Fogarty International Center | 2021 to 2025 | $1,686,671 | July 12, 2021 | March 31, 2027 | MANDALAKAS, ANNA M | reporter.nih.gov |
| Improved delivery of bNAbs for targeting CNS infection in infants | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,683,129 | September 18, 2024 | August 31, 2029 | WEN, JING | reporter.nih.gov |
| Impact of Neonatal ART and Broadly Neutralizing Antibodies on HIV-1 Reservoirs in Infants: Towards ART-free Remission | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,682,410 | July 22, 2024 | May 31, 2029 | PERSAUD, DEBORAH | reporter.nih.gov |
| Short-course rifapentine for TB prevention for all: clinical pharmacology matters | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,657,415 | August 7, 2024 | June 30, 2029 | DOOLEY, KELLY E. | reporter.nih.gov |
| Engaging communities to develop and evaluate communication strategies for HIV prevention among women in the Southern US | NIH | National Institute of Mental Health | 2024 to 2025 | $1,625,062 | August 15, 2024 | May 31, 2029 | DANG, BICH NGOC | reporter.nih.gov |
| Neonatal Immunity to novel TF SHIVs | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,624,728 | August 15, 2018 | January 31, 2029 | WILLIAMS, WILTON B | reporter.nih.gov |
| Advancing Multi-bNAbs Microneedle Patch Technology For HIV-1 Prevention in Breastfeeding Infants. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,597,030 | August 29, 2024 | June 30, 2029 | DONCEL, GUSTAVO F. | reporter.nih.gov |
| Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics | NIH | National Institute of Mental Health | 2025 | $1,583,791 | July 7, 2025 | May 31, 2030 | MCNULTY, MOIRA | reporter.nih.gov |
| Improving Choice and Use of Biomedical HIV Prevention for Women in Uganda: A Couples-Based Approach | NIH | National Institute of Mental Health | 2024 to 2025 | $1,550,745 | September 17, 2024 | June 30, 2028 | MINNIS, ALEXANDRA M | reporter.nih.gov |
| Identifying Unique Neural and Inflammatory Mechanisms of Depression in People Living with HIV | NIH | National Institute of Mental Health | 2024 to 2025 | $1,550,534 | September 1, 2024 | April 30, 2029 | BROOKS, JOHN O | reporter.nih.gov |
| CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,544,036 | August 29, 2020 | June 30, 2027 | TOMLINSON, MARK | reporter.nih.gov |
| Understanding reservoir effects and curative potential of a CD3/CCR5 bispecific antibody in infant macaques | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,499,079 | August 6, 2024 | July 31, 2029 | HARTIGAN-O'CONNOR, DENNIS J. | reporter.nih.gov |
| Long-term clinical and immunologic consequences of inflammation in perinatal HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,496,961 | August 7, 2024 | April 30, 2029 | KHAITAN, ALKA | reporter.nih.gov |
| Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,480,554 | April 14, 2020 | March 31, 2026 | PINTER, ABRAHAM | reporter.nih.gov |
| Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,467,856 | August 9, 2024 | July 31, 2029 | WEINBERG, ADRIANA | reporter.nih.gov |
| Defining the HIV reservoir and latency mechanism in human brain myeloid cells | NIH | National Institute of Mental Health | 2024 to 2025 | $1,452,825 | May 6, 2024 | March 31, 2029 | JIANG, GUOCHUN | reporter.nih.gov |
| Relationship between maternal and fetal immune responses | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,452,015 | September 19, 2022 | August 31, 2025 | WEINBERG, ADRIANA | reporter.nih.gov |
| Innate immune response of LTBI+HIV+ children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,390,281 | September 14, 2020 | February 18, 2024 | VANKAYALAPATI, RAMAKRISHNA | reporter.nih.gov |
| Deciphering hematopoietic stem cell defects in HIV exposed, uninfected infants born to ART-treated mothers | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,379,226 | May 8, 2024 | March 31, 2029 | RATHINAM, CHOZHA VENDAN | reporter.nih.gov |
| Enhanced problem-solving therapy and HIV engagement support to improve perinatal mental health and HIV outcomes in Malawi: A randomized controlled trial | NIH | National Institute of Mental Health | 2024 to 2025 | $1,363,051 | July 22, 2024 | February 28, 2029 | PENCE, BRIAN W | reporter.nih.gov |
| Addressing Research Gaps to Optimize Dolutegravir-based ART in Children and Adolescents | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,358,823 | August 5, 2024 | June 30, 2029 | KWARA, AWEWURA JACOB | reporter.nih.gov |
| Scaling up for impact: HIV testing counselor-led pathway to accelerate PrEP delivery at scale | NIH | National Institute of Mental Health | 2024 to 2025 | $1,357,697 | September 10, 2024 | June 30, 2029 | MUGWANYA, KENNETH KIGGUNDU | reporter.nih.gov |
| The Alama Project: Autism outcomes and neurobehavioral markers in young children born to mothers with HIV in Kenya | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,350,417 | September 17, 2024 | May 31, 2029 | MCNALLY KEEHN, REBECCA | reporter.nih.gov |
| Enhancing Novel Research for Inflammation and Cognitive Health among Adolescents and Young Adults Living with Perinatally Acquired HIV and Adversity (ENRICH+) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,348,550 | September 13, 2024 | May 31, 2029 | ROBBINS, REUBEN N | reporter.nih.gov |
| Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach | NIH | National Institute of Mental Health | 2024 to 2025 | $1,333,100 | September 16, 2024 | March 31, 2029 | SMITH, M KUMI | reporter.nih.gov |
| Virus and Host Directed Immunotherapies for Cure in SHIV-infected Infant Macaques | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,332,155 | June 10, 2025 | May 31, 2030 | CHAHROUDI, ANN M | reporter.nih.gov |
| AmbassADDOrs for Health: Maintaining youth-friendly HIV prevention services to young women through drug vendors | NIH | National Institute of Mental Health | 2024 to 2025 | $1,328,903 | August 15, 2024 | May 31, 2029 | LIU, JENNY XIN | reporter.nih.gov |
| A Randomized Control Trial of Striving Towards EmPowerment and Medication Adherence (STEP-AD) among Black Women Living with HIV | NIH | National Institute of Mental Health | 2024 to 2025 | $1,328,163 | March 1, 2024 | November 30, 2028 | DALE, SANNISHA K | reporter.nih.gov |
| Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters! A Theory-Based mHealth Intervention to Support Early Antiretroviral Adherence in HIV+ African Women Who Engage in Sex Work | NIH | National Institute of Mental Health | 2024 to 2025 | $1,326,098 | September 9, 2024 | June 30, 2028 | MCCLELLAND, RAYMOND SCOTT | reporter.nih.gov |
| MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,316,463 | April 3, 2020 | March 31, 2026 | GRAY, CLIVE MAURICE | reporter.nih.gov |
| Evaluation of PrEP implementation strategies for the general population in Botswana | NIH | National Institute of Mental Health | 2024 to 2025 | $1,309,260 | August 5, 2024 | May 31, 2029 | MOSEPELE, MOSEPELE | reporter.nih.gov |
| Research Training Program in Adolescent HIV in Haiti | NIH | Fogarty International Center | 2021 to 2024 | $1,305,920 | April 22, 2020 | December 31, 2025 | PAPE, JEAN WILLIAM | reporter.nih.gov |
| Child Mental Health in HIV-impacted Low-Resource Settings in Developing Countries: Global Research Fellowship | NIH | Fogarty International Center | 2021 to 2024 | $1,283,829 | April 22, 2020 | December 31, 2025 | SSEWAMALA, FRED M | reporter.nih.gov |
| Pediatric HIV Disclosure Intervention and Benefits Study-(PH-DIBS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $1,282,646 | August 15, 2020 | June 30, 2025 | PAINTSIL, ELIJAH | reporter.nih.gov |
| An early life multivalent immunization strategy for induction of neutralization breadth | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,275,484 | August 12, 2025 | June 30, 2030 | NELSON, ASHLEY NICOLE | reporter.nih.gov |
| Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control through PrEP: The IN-STEP study | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,258,067 | March 13, 2024 | January 31, 2029 | GRABOWSKI, MARY KATHRYN | reporter.nih.gov |
| Leveraging prenatal tolerance to improve AAV/bNAb therapy outcomes in infancy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,257,182 | August 1, 2025 | June 30, 2030 | MARTINS, MAURICIO A | reporter.nih.gov |
| Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,245,055 | April 3, 2020 | March 31, 2025 | NGCAPU, SINAYE | reporter.nih.gov |
| Mechanisms of Early-life Immunity Associated with HIV-1 Vaccine-induced Neutralizing Antibody Responses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,239,565 | August 20, 2025 | June 30, 2030 | WILLIAMS, WILTON B | reporter.nih.gov |
| Scale-up of an evidence-based Adolescent Transition Package to support transitional care among youth living with HIV | NIH | National Institute of Mental Health | 2024 to 2025 | $1,237,994 | September 11, 2024 | June 30, 2029 | JOHN-STEWART, GRACE C. | reporter.nih.gov |
| Improving understanding of Capacity to consent to sensitive biomedical HIV prevention Research among adolescents in Rakai Uganda (ICARE) | NIH | National Institute of Mental Health | 2024 to 2025 | $1,228,797 | April 8, 2024 | January 31, 2029 | KRENISKE, PHILIP | reporter.nih.gov |
| Dose flexible ultra-long-acting prodrug formulations for pediatric populations | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,228,661 | January 17, 2025 | December 31, 2026 | EDAGWA, BENSON | reporter.nih.gov |
| In This toGether: Testing a population-based text messaging-based HIV prevention program for young adults across Uganda | NIH | National Institute of Mental Health | 2024 to 2025 | $1,210,902 | June 12, 2024 | January 31, 2029 | YBARRA, MICHELE L. | reporter.nih.gov |
| Identifying critical determinants of vaccine-induced cellular and humoral immunity from birth through childhood in HIV-exposed and unexposed children | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,202,470 | November 20, 2023 | October 31, 2027 | SLYKER, JENNIFER ANN | reporter.nih.gov |
| Adolescent Health Training Program | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,199,421 | May 1, 2006 | April 30, 2027 | TRENT, MARIA E. | reporter.nih.gov |
| Kupewa: Optimizing implementation strategies for cervical cancer prevention | NIH | National Cancer Institute | 2024 to 2025 | $1,199,376 | September 1, 2024 | August 31, 2029 | MOUCHERAUD, CORRINA | reporter.nih.gov |
| HIS : Training Tanzanian Researchers for HIV/AIDS Implementation Science (Renewal) | NIH | Fogarty International Center | 2022 to 2025 | $1,189,716 | May 18, 2015 | April 30, 2027 | SUDFELD, CHRISTOPHER | reporter.nih.gov |
| Scaling up integrated PrEP delivery in Kenyan maternal and child health clinics for pregnant and postpartum women | NIH | National Institute of Mental Health | 2024 to 2025 | $1,175,784 | January 1, 2024 | October 31, 2028 | WAGNER, ANJULI DAWN | reporter.nih.gov |
| Integrase Inhibitors during pregnancy and Neurodevelopmental Outcomes: Underlying Mechanism and Therapeutic Intervention | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,146,890 | May 15, 2024 | April 30, 2029 | BADE, ADITYA N | reporter.nih.gov |
| Post-Tuberculosis Lung Disease in Youth with and without HIV Globally | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,136,143 | August 22, 2025 | July 31, 2030 | ENANE, LESLIE ANNE | reporter.nih.gov |
| High Dose Oral Rifampicin to Improve Survival from Adult Tuberculous Meningitis: a pharmacokinetic substudy (HARVEST-PK) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,122,044 | January 22, 2024 | November 30, 2028 | TE BRAKE, LINDSEY | reporter.nih.gov |
| Interdisciplinary And Translational Research Training In Neurohiv | NIH | National Institute of Mental Health | 2021 to 2025 | $1,110,466 | July 1, 2008 | August 31, 2030 | KHALILI, KAMEL | reporter.nih.gov |
| Streamlined Treatment and Evidence-based Adolescent counseling and Medication Support (STREAMS) | NIH | National Institute of Mental Health | 2025 | $1,057,586 | September 19, 2025 | May 31, 2030 | KRENISKE, PHILIP | reporter.nih.gov |
| Clinical outcomes of HIV-exposed uninfected children during mid-childhood in rural Zimbabwe | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,028,670 | August 21, 2020 | February 28, 2026 | PRENDERGAST, ANDREW | reporter.nih.gov |
| Vaginal Microbiome and Metabolites in Preterm Birth | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $990,612 | August 10, 2021 | July 31, 2026 | POWELL, ANNA MAYA | reporter.nih.gov |
| Mentoring in patient-oriented research to finding a cure for HIV-1 infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $958,485 | July 13, 2021 | June 30, 2026 | LICHTERFELD, MATHIAS | reporter.nih.gov |
| Mind the gaps: Pharmacokinetic research to advance pediatric HIV/TB cotreatment and TB prevention | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $936,346 | April 7, 2022 | January 31, 2028 | RAWIZZA, HOLLY ELIZABETH | reporter.nih.gov |
| Mentoring in Patient-Oriented HIV Research in the Era of Universal ART | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $928,483 | March 1, 2017 | June 30, 2027 | LOCKMAN, SHAHIN | reporter.nih.gov |
| An interactive, narrative intervention to address the mental health treatment gap among young people living with HIV in Nigeria | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $913,737 | March 8, 2024 | June 30, 2027 | AHONKHAI, AIMALOHI | reporter.nih.gov |
| Expansion of research and mentoring opportunities to reduce the burden of maternal and pediatric HIV in Botswana | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $910,535 | February 5, 2018 | July 31, 2028 | SHAPIRO, ROGER L | reporter.nih.gov |
| Creating, evaluating, and sharing synthetic data for multinational HIV cohorts | NIH | National Institute of Mental Health | 2025 | $873,570 | May 2, 2025 | February 28, 2030 | SHEPHERD, BRYAN EARL | reporter.nih.gov |
| In-depth characterization of myeloid cells in human milk from HIV- and HIV+ donors as potential vehicles of and defenders against vertical transmission of HIV: essential data for targeted therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $850,491 | September 19, 2025 | August 31, 2030 | POWELL, REBECCA | reporter.nih.gov |
| Optimizing an mHealth intervention to improve uptake and adherence of the HIV pre-exposure prophylaxis (PrEP) in vulnerable adolescents and emerging adults | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $836,621 | August 13, 2021 | July 31, 2027 | WANG, BO | reporter.nih.gov |
| Basic Income Guarantee Chicago: A Trial of Basic Income | NIH | National Institute of Mental Health | 2025 | $819,998 | August 6, 2025 | May 31, 2030 | PAGKAS-BATHER, JADE | reporter.nih.gov |
| Longitudinal Cognitive Outcomes in Children and Adolescents with HIV in Zambia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $816,891 | July 1, 2020 | June 30, 2025 | BEARDEN, DAVID ROSS | reporter.nih.gov |
| Relevance of Resistance Mutations for the Susceptibility to Broadly Neutralizing Antibodies Against HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $798,480 | September 1, 2021 | August 31, 2026 | JILG, NIKOLAUS | reporter.nih.gov |
| PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking | NIH | National Institute of Mental Health | 2025 | $790,198 | September 18, 2025 | May 31, 2030 | MUGAVERO, MICHAEL J | reporter.nih.gov |
| Integrating PrEP Decision-Making into Contraceptive Counseling in Family Planning Clinics | NIH | National Institute of Mental Health | 2024 | $777,440 | September 6, 2024 | September 5, 2027 | MEYER, JAIMIE | reporter.nih.gov |
| Improving wellbeing, HIV prevention, and intersectional stigma among multiply marginalized Chinese women in NYC | NIH | National Institute of Mental Health | 2025 | $777,437 | February 1, 2025 | January 31, 2028 | LIM, SAHNAH | reporter.nih.gov |
| Improving the Treatment of Depression among Youth with HIV | NIH | National Institute of Mental Health | 2025 | $768,260 | August 1, 2025 | April 30, 2030 | BROWN, LARRY K | reporter.nih.gov |
| Integrated HIV and Overdose Prevention in Pharmacies: Assessing Availability and Implementation Strategies in Different Policy Environments (HIP-Pharm) | NIH | National Institute on Drug Abuse | 2025 | $762,479 | July 1, 2025 | March 31, 2030 | LANCASTER, KATHRYN ELIZABETH | reporter.nih.gov |
| Quantifying integrase resistance among Nigerian children failing dolutegravir to inform rapid diagnostic development in partnership with Nigerian scientists | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $755,674 | March 18, 2024 | January 31, 2029 | RAWIZZA, HOLLY ELIZABETH | reporter.nih.gov |
| Streamlining Telehealth for Expanded PrEP Utilization through community Partnerships (STEP-UP) | NIH | National Institute of Mental Health | 2025 | $744,279 | September 18, 2025 | September 17, 2028 | BONETT, STEPHEN | reporter.nih.gov |
| Health Coaching to Improve Comprehensive HIV and Sexually Transmitted Infection Prevention in Adolescent Primary Care | NIH | National Institute of Mental Health | 2021 to 2024 | $740,318 | January 1, 2020 | July 31, 2024 | WOOD, SARAH MARIAN | reporter.nih.gov |
| Impact of HIV and toxic metals exposure on neurodevelopment at school age | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $734,151 | September 10, 2025 | May 31, 2026 | JOHN-STEWART, GRACE C. | reporter.nih.gov |
| Evaluating Social Brain Health in HIV: An RDoC-based approach | NIH | National Institute of Mental Health | 2025 | $733,355 | March 1, 2025 | January 31, 2030 | LEE, JUNGHEE | reporter.nih.gov |
| Optimizing measurement and evaluating the health impacts of stigma among populations at risk for and living with HIV | NIH | National Institute of Mental Health | 2025 | $733,314 | September 23, 2025 | August 31, 2030 | BARAL, STEFAN DAVID | reporter.nih.gov |
| Randomized controlled trial of an agricultural livelihood intervention to improve maternal and newborn health and nutrition in Kenya | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $731,750 | January 17, 2025 | December 31, 2029 | COHEN, CRAIG R | reporter.nih.gov |
| A Pilot Feasibility Study to Integrate PrEP into Emergency Departments using Decision Support Tools | NIH | National Institute of Mental Health | 2025 | $731,738 | September 10, 2025 | September 9, 2028 | CASTEL, AMANDA DERRYCK | reporter.nih.gov |
| Leveraging telehealth to optimize PrEP and PEP delivery at pharmacies in Kenya | NIH | National Institute of Mental Health | 2025 | $729,286 | September 12, 2025 | June 30, 2030 | ORTBLAD, KATRINA FRANCES | reporter.nih.gov |
| Innate immune response of LTBI+HIV+ children | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $726,289 | September 14, 2020 | January 31, 2026 | VANKAYALAPATI, RAMAKRISHNA | reporter.nih.gov |
| Modeling the Effects of HIV, Chlamydia, and Gonorrhea in Mother-Infant Pairs in Botswana. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $725,325 | March 2, 2020 | May 31, 2025 | DUGDALE, CAITLIN | reporter.nih.gov |
| Understanding individual- and social network-level factors affecting infant HIV testing to design social network interventions to increase testing of HIV-exposed infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $722,447 | July 1, 2021 | June 30, 2027 | COMFORT, ALISON B | reporter.nih.gov |
| Identifying the mechanisms of water insecurity on HIV treatment outcomes | NIH | National Institute of Mental Health | 2024 | $722,368 | July 1, 2024 | December 31, 2025 | OUNER, JERRY JOHN | reporter.nih.gov |
| Interactive Internet-based Motivational Interviewing Training for HIV Counseling Support Staff to Improve Health Communication in HIV Care Interactions | NIH | National Institute of Mental Health | 2024 | $714,765 | February 1, 2024 | January 31, 2027 | BALAN, IVAN C | reporter.nih.gov |
| Modeling reductions in harmful alcohol use on HIV transmission and mortality in the era of universal test and treat in Uganda | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $710,164 | September 25, 2020 | August 31, 2025 | WYNN, ADRIANE MICHELLE | reporter.nih.gov |
| An AI-based behavioral intervention to improve pre-exposure prophylaxis for HIV prevention | NIH | National Institute of Mental Health | 2025 | $705,322 | September 16, 2025 | September 15, 2028 | TAO, JUN | reporter.nih.gov |
| Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkers | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $702,975 | May 1, 2020 | April 30, 2026 | KANE, JEREMY CALVIN | reporter.nih.gov |
| Strengthening Families Living with HIV in Kenya | NIH | National Institute of Mental Health | 2021 to 2024 | $693,806 | September 1, 2020 | August 31, 2025 | GOODMAN, MICHAEL | reporter.nih.gov |
| Adaptation of a digital health HIV prevention intervention for Black heterosexual couples in New York State | NIH | National Institute of Mental Health | 2024 | $692,070 | September 4, 2024 | August 31, 2027 | LEBLANC, NATALIE MARIE | reporter.nih.gov |
| Developing an online decision support approach leveraging social media to promote PrEP awareness and demand among women in the Southeastern US | NIH | National Institute of Mental Health | 2025 | $691,620 | September 22, 2025 | September 21, 2028 | HILL, LAUREN | reporter.nih.gov |
| Understanding Medication Adherence Benchmarks, Safety and Pharmacometrics of Novel Antiretrovirals in Pregnant Women Living with HIV. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $685,143 | September 25, 2020 | August 31, 2025 | EKE, AHIZECHUKWU C. | reporter.nih.gov |
| Reaching persons with HIV who are out of care through Expedited access to Long-Acting Injectable antiretroviral therapy -"RELAI" | NIH | National Institute of Mental Health | 2025 | $684,765 | September 23, 2025 | September 22, 2028 | RUTSTEIN, SARAH E. | reporter.nih.gov |
| A family-based intervention to improve HIV pre-exposure prophylaxis uptake for adolescent sexual minority males | NIH | National Institute of Mental Health | 2021 to 2024 | $673,918 | May 1, 2020 | April 30, 2026 | RUSLEY, JACK | reporter.nih.gov |
| HIV drug resistance, monitoring and transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $669,989 | March 1, 2018 | December 31, 2028 | KANTOR, RAMI | reporter.nih.gov |
| Harnessing Data Science to Improve HIV Care Continuum Outcomes: A Hybrid Type 2 Trial Evaluating a Machine-Learning Algorithm-Based Implementation Strategy | NIH | National Institute of Mental Health | 2025 | $669,291 | March 1, 2025 | January 31, 2030 | GOLUB, SARIT A | reporter.nih.gov |
| Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda. | NIH | National Institute of Mental Health | 2025 | $665,225 | January 1, 2025 | December 31, 2029 | SSEWAMALA, FRED M | reporter.nih.gov |
| Optimizing mobile interventions to overcome stigma and promote HIV prevention among Thai young transgender women | NIH | National Institute of Mental Health | 2024 | $664,382 | August 15, 2024 | August 14, 2027 | WANG, BO | reporter.nih.gov |
| Ongoing Dynamic Choice to Address HIV Treatment Interruption in Malawi (CHOICE) | NIH | National Institute of Mental Health | 2025 | $653,677 | April 1, 2025 | January 31, 2030 | DOVEL, KATHRYN L | reporter.nih.gov |
| Innate Immune Defects in HIV-Exposed Uninfected Infants: Effect on Respiratory Syncytial Virus Infection | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $648,172 | March 1, 2020 | February 28, 2026 | SMITH-ANDERSON, CHRISTIANA ELIZABETH | reporter.nih.gov |
| Adaptation and Implementation of an Evidence-Based Approach to Advance HIV Prevention and Care | NIH | National Institute of Mental Health | 2025 | $639,615 | January 10, 2025 | January 9, 2027 | LIN, CHUNQING | reporter.nih.gov |
| Prison-Based HIV Partner Notification in Indonesia | NIH | National Institute of Mental Health | 2025 | $637,749 | February 1, 2025 | January 31, 2030 | CULBERT, GABRIEL JOHN | reporter.nih.gov |
| Optimizing PrEP uptake for African American women in the South by empowering women to make informed HIV prevention and sexual health choices | NIH | National Institute of Mental Health | 2024 | $632,775 | September 1, 2024 | August 31, 2027 | HAIDER, MOHAMMAD RIFAT | reporter.nih.gov |
| Feasibility of a community-engaged social marketing strategy to reduce HIV-related stigma and improve health among young people | NIH | Fogarty International Center | 2022 to 2024 | $631,289 | July 1, 2022 | May 19, 2025 | FRANKE, MOLLY FORREST | reporter.nih.gov |
| Evaluating the Camino intervention to reduce HIV risk and poor care outcomes among Latin Americans | NIH | National Institute of Mental Health | 2025 | $608,698 | September 17, 2025 | September 16, 2028 | YAMANIS, THESPINA JEANNE | reporter.nih.gov |
| Understanding viral mechanisms to inform oncolytic therapies for EBV-associated lymphomas in PLWH | NIH | National Institute of Dental & Craniofacial Research | 2025 | $601,309 | July 1, 2025 | March 31, 2030 | BHADURI-MCINTOSH, SUMITA | reporter.nih.gov |
| Cross-disciplinary approach to understanding the long-term impact of HIV exposure in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $598,566 | September 16, 2025 | June 30, 2030 | LAURENS, MATTHEW BRENT | reporter.nih.gov |
| HIV viral suppression and prevention of postpartum weight retention in South Africa: A pilot trial | NIH | National Institute of Mental Health | 2024 | $594,148 | September 15, 2024 | September 14, 2027 | PELLOWSKI, JENNIFER ANN | reporter.nih.gov |
| Adolescent sexual relationships over time | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $581,312 | August 20, 2021 | June 30, 2027 | NELSON, KIMBERLY M | reporter.nih.gov |
| Reducing the intersecting stigmas of HIV, violence victimization, and mental health: a randomized controlled pilot integrating Project YES! Youth Engaging for Success and Problem Management Plus amon | NIH | Fogarty International Center | 2022 to 2024 | $563,002 | September 1, 2022 | June 30, 2026 | DENISON, JULIE ANNE | reporter.nih.gov |
| Secondary distribution of HIV self-testing by FSW, pre-exposure prophylaxis (PrEP) starter packs and brief counseling to promote PrEP initiation and persistence among high-risk men in Uganda | NIH | National Institute of Mental Health | 2024 | $547,321 | July 1, 2024 | June 30, 2027 | BUREGYEYA, ESTHER | reporter.nih.gov |
| Early life determinants of cardiometabolic health from birth to adolescence amongst HIV-exposed and unexposed South African children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $537,379 | August 18, 2022 | July 31, 2027 | PELLOWSKI, JENNIFER ANN | reporter.nih.gov |
| Iron and folic acid supplementation strategies during pregnancy and adverse pregnancy outcomes in Botswana | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $530,820 | August 1, 2021 | July 31, 2025 | CANIGLIA, ELLEN CHRISTINA | reporter.nih.gov |
| A self-administered PrEP Decisional Aid for dissemination with HIV self-test kits (DASH) | NIH | National Institute of Mental Health | 2024 to 2025 | $498,842 | May 15, 2024 | February 28, 2027 | AMICO, KATHY RIVET | reporter.nih.gov |
| Identifying inter-kingdom microbial determinants of altered immunity in HIV exposed infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $492,522 | September 12, 2024 | July 31, 2027 | BROWN, BRYAN P | reporter.nih.gov |
| The role of CSF Memory B cells in neuropathogenesis in PWH on ART | NIH | National Institute of Mental Health | 2025 | $491,700 | September 3, 2025 | September 2, 2027 | FARHADIAN, SHELLI | reporter.nih.gov |
| Clinical and implementation outcomes of a point of care sexually transmitted infection testing strategy to improve HIV prevention service delivery in adolescents | NIH | National Institute of Mental Health | 2025 | $490,550 | June 9, 2025 | June 8, 2027 | WOOD, SARAH MARIAN | reporter.nih.gov |
| Impact of geographic mobility on pre-exposure prophylaxis and HIV care outcomes | NIH | National Institute of Mental Health | 2024 to 2025 | $486,009 | September 1, 2024 | June 30, 2027 | TIEU, HONG VAN NHU | reporter.nih.gov |
| Influence of Social Networks on HIV Testing and PrEP Care among Young Latin American Gay, Bisexual, and Other Men Who Have Sex with Men | NIH | National Institute of Mental Health | 2025 | $485,131 | September 22, 2025 | September 21, 2027 | TIEU, HONG VAN NHU | reporter.nih.gov |
| The effect of the maternal plasma and breastmilk metabolome on the infant gut microbiome and growth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $483,000 | August 18, 2023 | June 30, 2028 | HENDRIXSON, DAVID TAYLOR | reporter.nih.gov |
| Dissecting the causal impact of prenatal HIV exposure and the postnatal environment on development in Malawian Infants | NIH | National Institute of Mental Health | 2023 to 2025 | $467,790 | July 1, 2023 | June 30, 2028 | BUCHWALD, ANDREA G. | reporter.nih.gov |
| Participatory System Dynamics to Enhance PrEP Access in Bronx, NY | NIH | National Institute of Mental Health | 2024 to 2025 | $462,000 | September 1, 2024 | August 31, 2026 | ROSS, JONATHAN | reporter.nih.gov |
| Identifying key engagement characteristics to enhance the effectiveness of digital HIV interventions for at-risk youth | NIH | National Institute of Mental Health | 2025 | $457,596 | August 1, 2025 | July 31, 2027 | CHOI, SEUL KI | reporter.nih.gov |
| WePrEP: Facilitating personal autonomy in HIV prevention through shared decision-making about PrEP for women in the US | NIH | National Institute of Mental Health | 2024 to 2025 | $457,086 | May 1, 2024 | February 28, 2027 | RAEL, CHRISTINE TAGLIAFERRI | reporter.nih.gov |
| Examining adolescent mothers' engagement in HIV prevention across high burden HIV countries in Sub Saharan Africa | NIH | National Institute of Mental Health | 2024 | $456,393 | January 18, 2024 | December 31, 2025 | GROVES, ALLISON K. | reporter.nih.gov |
| Appetite regulation with DTG based ART in postpartum women living with HIV and their infants (Ar-DART) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $452,784 | August 6, 2024 | July 31, 2026 | AIZIRE, JIM K | reporter.nih.gov |
| Community-Engage?Modeling?and Implementation Science to Develop Re-Linkage Interventions for Black Men who have Sex with Men with HIV | NIH | National Institute of Mental Health | 2024 to 2025 | $450,896 | September 1, 2024 | August 31, 2026 | HOTTON, ANNA | reporter.nih.gov |
| Persistence of HIV-specific CD8+ T cell responses after long-term ART in early treated Thai children | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $433,384 | July 5, 2024 | May 31, 2027 | MITCHELL, JULIE | reporter.nih.gov |
| Improving HIV testing among Children under five in Rural Uganda | NIH | National Institute of Mental Health | 2024 | $431,712 | August 1, 2024 | July 31, 2026 | HOOFT, ANNEKA M | reporter.nih.gov |
| Exploring sustained implementation and fidelity of an evidence-based HIV prevention program | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $425,210 | August 12, 2024 | July 31, 2026 | WANG, BO | reporter.nih.gov |
| Imaging Biomarker for Determining Antiretroviral-induced Neurodevelopmental Impairments | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $422,125 | July 1, 2025 | June 30, 2027 | BADE, ADITYA N | reporter.nih.gov |
| Virologic and Immunologic Correlates of Disease Progression in Perinatal HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $417,162 | December 8, 2023 | November 30, 2026 | KHAITAN, ALKA | reporter.nih.gov |
| Ionic liquid-based nanoemulsion containing combination antiretroviral drugs forthe transdermal treatment of pediatric HIV infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $414,522 | August 7, 2024 | June 30, 2026 | DATE, ABHIJIT A | reporter.nih.gov |
| A trauma-informed approach to increase HIV prevention and care engagement in a population with elevated HIV burden | NIH | National Institute of Mental Health | 2024 to 2025 | $395,496 | July 1, 2024 | June 30, 2029 | BAGUSO, GLENDA | reporter.nih.gov |
| Telephone Initiated PrEP Post-ED Discharge (TIPPED) | NIH | National Institute of Mental Health | 2024 to 2025 | $389,869 | May 10, 2024 | April 30, 2029 | SOLNICK, RACHEL EMILY | reporter.nih.gov |
| Meeting adolescent girls and young women who experience intimate partner violence where they are: Developing an implementation strategy for linkage to PrEP options | NIH | National Institute of Mental Health | 2024 to 2025 | $384,362 | August 1, 2024 | July 31, 2027 | GIOVENCO, DANIELLE | reporter.nih.gov |
| The relationship between HIV exposure, contact networks, and TB in children under 5 years old | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $383,828 | August 20, 2024 | July 31, 2029 | CAMPBELL, JEFFREY IAN | reporter.nih.gov |
| Leveraging Social Networks to Promote PrEP among Young Men | NIH | National Institute of Mental Health | 2024 to 2025 | $373,680 | September 1, 2024 | August 31, 2028 | SHAH, HARITA | reporter.nih.gov |
| Using Implementation Science to Enhance HIV Prevention for Young Men | NIH | National Institute of Mental Health | 2024 to 2025 | $364,832 | August 15, 2024 | July 31, 2029 | BARNETT, ANDREW P | reporter.nih.gov |
| Impact of an Intervention to Expand Pharmacist Capacity to Prescribe HIV Pre-exposure Prophylaxis | NIH | National Institute of Mental Health | 2024 to 2025 | $363,881 | September 1, 2024 | August 31, 2029 | SAEED, ABUBAKER | reporter.nih.gov |
| Mapping social network disruptions, HIV, and intervention strategies among women with multistate living patterns in the U.S. | NIH | National Institute of Mental Health | 2024 to 2025 | $363,877 | August 27, 2024 | July 31, 2029 | HILL, MIRANDA | reporter.nih.gov |
| Exploring synergies in pharmacy-based delivery of PrEP and contraception for adolescent girls and young women in Kenya | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $359,992 | September 11, 2024 | August 31, 2026 | HARRINGTON, ELIZABETH K | reporter.nih.gov |
| Designing adaptive implementation strategies for mental health care in persons living with HIV (DASH) | NIH | National Institute of Mental Health | 2024 to 2025 | $359,621 | September 1, 2024 | August 31, 2029 | FILIATREAU, LINDSEY | reporter.nih.gov |
| Preventing disruptions in progress towards ending HIV/AIDS: Lessons from the COVID-19 pandemic | NIH | National Institute of Mental Health | 2024 to 2025 | $354,013 | March 21, 2024 | February 28, 2029 | GIOVENCO, DANIELLE | reporter.nih.gov |
| BIOLOGICAL AGING AND COGNITIVE IMPAIRMENT IN PERSONS WITH HIV | NIH | National Institute of Mental Health | 2024 to 2025 | $338,974 | July 1, 2024 | June 30, 2029 | PETERSEN, KALEN J. | reporter.nih.gov |
| Leveraging video logs as a bridge to pre-exposure prophylaxis (PrEP) with tailored messaging to Black women and their healthcare providers in Texas | NIH | National Institute of Mental Health | 2025 | $337,226 | December 1, 2024 | July 31, 2027 | HILL, MANDY J | reporter.nih.gov |
| Influence of fetal antiretroviral exposure on gut microbiota, systemic inflammation and neurodevelopment in infants exposed to HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $318,362 | March 1, 2023 | February 28, 2026 | HAPPEL, ANNA-URSULA | reporter.nih.gov |
| Longitudinal Oral Microbiome for HIV/HEU/HUU Children Aged 3-4 in Western Kenya | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $315,000 | September 20, 2024 | August 31, 2026 | WANG, YAN | reporter.nih.gov |
| Mobile phone-based screening for anemia in young children in western Kenya | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $310,414 | September 21, 2023 | August 30, 2028 | MCGANN, PATRICK THOMAS | reporter.nih.gov |
| Strengthening capacity of researchers in Uganda to conduct HIV treatment and prevention clinical trials in perinatal, paediatric, adolescent, and at risk populations including women and their partners | NIH | Fogarty International Center | 2025 | $302,142 | July 1, 2025 | March 31, 2030 | MUSOKE, PHILIPPA | reporter.nih.gov |
| Implementation of Confidential Care to Increase Adolescent HIV Testing in Pediatric Primary Care Settings | NIH | National Institute of Mental Health | 2024 to 2025 | $299,479 | May 15, 2024 | April 30, 2029 | AIVADYAN, CHRISTINA MARIA | reporter.nih.gov |
| PHARMACOKINETICS AND PHARMACOGENOMICS OF DOLUTEGRAVIR-BASED ANTIRETROVIRAL THERAPY IN YOUNG PEOPLE LIVING WITH HIV IN GHANA (PHARMA-YOUNG-HIV) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $298,525 | August 16, 2024 | July 31, 2026 | THOMFORD, NICHOLAS EKOW | reporter.nih.gov |
| The role of monocyte metabolism and migration in inflammation-related reward circuit deficits and symptoms of anhedonia in people with HIV | NIH | National Institute of Mental Health | 2024 to 2025 | $293,972 | May 1, 2024 | April 30, 2029 | BEKHBAT, MANDAKH | reporter.nih.gov |
| The effect of inherited maternal cells on BCG-specific T cell responses in HIV exposed and unexposed infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $293,550 | September 5, 2025 | August 31, 2027 | HARRINGTON, WHITNEY ELIZABETH | reporter.nih.gov |
| Defining and modeling HIV-1-specific antibody function in HIV-1-exposed Infants passively Infused with broadly neutralizing antibodies in the IMPAACT P1112 trial. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $273,424 | April 9, 2025 | March 31, 2027 | FOUDA AMOU OU, GENEVIEVE GINY | reporter.nih.gov |
| Feasibility, acceptability, and preliminary efficacy of an adapted group-based and online HIV prevention intervention for immigrant sexual minority men in the US | NIH | National Institute of Mental Health | 2024 | $270,250 | September 11, 2024 | March 21, 2025 | ABBOUD, SARAH | reporter.nih.gov |
| IMPILO: Investigating novel 6-Month regimens for RR-TB in Pregnancy and Lactation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $265,672 | May 10, 2024 | April 30, 2029 | LOVEDAY, MARIAN | reporter.nih.gov |
| MAGIC-PHIV: Microbiome and Gut Inflammation in Cardiometabolic Health in Youth with Perinatally Acquired HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $265,369 | September 1, 2025 | August 31, 2027 | DIRAJLAL-FARGO, SAHERA | reporter.nih.gov |
| Developing and pilot testing an eHealth decision support tool for young trans women to improve informed decision making about PrEP | NIH | National Institute of Mental Health | 2024 | $264,871 | September 1, 2024 | March 21, 2025 | BASS, SARAH B | reporter.nih.gov |
| Functional longevity of maternally derived antibodies against group B Streptococcus and respiratory syncytial virus in HIV-exposed uninfected and HIV-unexposed uninfected infants. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $264,667 | January 11, 2024 | December 31, 2025 | DZANIBE, SONWABILE | reporter.nih.gov |
| AAV-delivery of broadly neutralizing antibodies to augment ART-free control of HIV-1 in children | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $251,250 | August 5, 2025 | July 31, 2026 | LUZURIAGA, KATHERINE F. | reporter.nih.gov |
| Impact of in utero HIV and antiretroviral exposure on the placenta and birth weight | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $244,328 | January 6, 2025 | December 31, 2026 | BEBELL, LISA M | reporter.nih.gov |
| Influence of Early Life Gut Microbiota of HIV-Exposed Uninfected Infants on Inflammation, Growth and Immunity to Enteric Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $243,050 | August 3, 2023 | July 31, 2025 | NYANGAHU, DONALD | reporter.nih.gov |
| PEP/PrEP via Pharmacist-Prescribing Implementation (PEPPI) | NIH | National Institute of Mental Health | 2025 | $242,827 | September 22, 2025 | August 31, 2026 | RAFIE, SALLY | reporter.nih.gov |
| Evaluating extent and outcomes of isoniazid exposure during pregnancy among infants born to women living with HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $233,250 | September 25, 2025 | August 31, 2027 | PINTYE, JILLIAN | reporter.nih.gov |
| Uncovering the Biological Link between Oral and Mental health in Adolescents Living with HIV (uBLOoM) | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2024 | $232,726 | August 1, 2023 | August 2, 2024 | COKER, MODUPE | reporter.nih.gov |
| Virologic Determinants of Very Early Antiretroviral Treatment Responses of Infants with in utero HIV-1 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $232,500 | April 16, 2025 | March 31, 2027 | PERSAUD, DEBORAH | reporter.nih.gov |
| International Workshops on HIV Pediatrics | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $224,997 | August 1, 2022 | March 13, 2025 | ABRAMS, ELAINE JANINE | reporter.nih.gov |
| Mentoring Clinical Investigators in Psychedelic-Assisted Therapy for HIV (Mentor-PATH) | NIH | National Institute on Drug Abuse | 2025 | $216,678 | August 1, 2025 | July 31, 2030 | SABERI, PARYA | reporter.nih.gov |
| Targeting Tfh differentiation to increase the magnitude and durability of antibody responses in infant rhesus macaques after SHIV infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $214,996 | September 1, 2025 | August 31, 2028 | MITCHELL, JULIE | reporter.nih.gov |
| Leveraging antibody-omics to prevent and detect TB in children affected by HIV | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $209,750 | May 22, 2025 | April 30, 2027 | CRANMER, LISA M | reporter.nih.gov |
| Engaging men outside the HIV prevention paradigm in rural South Africa | NIH | National Institute of Mental Health | 2025 | $197,035 | January 1, 2025 | December 31, 2029 | CASTLE, ALISON CLARE | reporter.nih.gov |
| Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP | NIH | National Institute of Mental Health | 2025 | $193,754 | April 15, 2025 | March 31, 2030 | GUSS, CARLY | reporter.nih.gov |
| Improving Personalized Communication Among Pharmacy Staff Caring for PrEP seekers: Development and Pilot of an Anti-stigma Intervention using Implementation Science | NIH | National Institute of Mental Health | 2025 | $191,117 | September 1, 2025 | August 31, 2030 | KISLOVSKIY, YASASWI | reporter.nih.gov |
| Developing a Community Health Worker-delivered PrEP Decision Aid to Facilitate PrEP Initiation in Black Women Seeking HIV Testing Services in Eastern Virginia | NIH | National Institute of Mental Health | 2025 | $179,731 | September 1, 2025 | August 31, 2030 | SHANGANI, SYLVIA | reporter.nih.gov |
| Planning for Implementation of a Family-based Intervention for Prevention of HIV, Substance Use, and Mental Health Problems among Hispanic Youth at Risk: A Community-Engaged Approach | NIH | National Institute of Mental Health | 2025 | $176,083 | September 22, 2025 | August 31, 2030 | LOZANO, ALYSSA | reporter.nih.gov |
| HIV and ART Disruptions in Glial Cell Lipid Metabolism and its Effect on Adolescent Myelination | NIH | National Institute of Mental Health | 2024 to 2025 | $168,380 | April 1, 2024 | March 31, 2027 | JEFFRIES, MARISA | reporter.nih.gov |
| Adapting the ESTEEM intervention to improve mental health and PrEP uptake among men at risk of HIV | NIH | National Institute of Mental Health | 2025 | $160,931 | April 20, 2024 | March 31, 2029 | DAVIS, DIRK ALEXANDER | reporter.nih.gov |
| ESTEEM | NIH | National Institute of Mental Health | 2024 | $159,276 | April 20, 2024 | March 31, 2029 | DAVIS, DIRK ALEXANDER | reporter.nih.gov |
| Association between adverse maternal factors and neurodevelopmental outcomes among children in Kenya | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $153,860 | September 16, 2024 | September 15, 2026 | TIWARI, RUCHI | reporter.nih.gov |
| Harnessing Heterogeneity to Isolate and Eradicate the Clonal CD4 HIV Reservoir | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $149,389 | August 11, 2025 | July 31, 2027 | FERREIRA, ISABELLA | reporter.nih.gov |
| High-resolution malaria parasite and drug dynamics in the context of antimalarial treatment and drug resistance selection | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $127,389 | May 1, 2022 | April 30, 2025 | GOODWIN, JUSTIN | reporter.nih.gov |
| CLINICAL TRIALS ACCRUAL QUALITY IMPROVEMENT PROGRAM (AQUIP) DATA AND INFORMATION TECHNOLOGY SUPPORT FOR THE US-LATIN AMERICAN-CARIBBEAN HIV/HPV PREVENTION CLINICAL TRIALS NETWORK (ULACNET) | NIH | National Cancer Institute | 2024 | $119,832 | June 3, 2024 | June 2, 2026 | KESSLAR, TIMOTHY | reporter.nih.gov |
| Understanding HIV testing, HIV care engagement, and the implementation of HIV prevention strategies for priority populations in the Southern United States | NIH | National Institute of Mental Health | 2024 to 2025 | $98,512 | July 1, 2024 | June 30, 2027 | O'NEIL, ANDREW M | reporter.nih.gov |
| The Effects of Structural Inequities and Syndemics on Willingness to Participate in HIV Research among Black Women | NIH | National Institute of Mental Health | 2024 to 2025 | $93,965 | May 1, 2024 | April 30, 2026 | CAMPBELL, DANIELLE M | reporter.nih.gov |
| Reimagining HIV Prevention: Unveiling Opportunities to Strengthen Sexual Reproductive Health Services and Promote HIV Prevention among Cisgender Black Women at risk for HIV in Maryland | NIH | National Institute of Mental Health | 2024 to 2025 | $89,863 | January 1, 2024 | December 31, 2025 | DUROSEAU, BRENICE | reporter.nih.gov |
| The impact of forced migration on HIV vulnerability and prevention among internally displaced adolescent girls and young women in northern Mozambique | NIH | National Institute of Mental Health | 2024 to 2025 | $89,460 | July 1, 2024 | June 30, 2026 | CHANTRE, CATHERINE LIMA | reporter.nih.gov |
| Characterizing adherence and estimating per-protocol effects for pediatric dolutegravir use | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $89,179 | June 1, 2024 | May 31, 2028 | LI, CATHERINE XIN-DI | reporter.nih.gov |
| Training in Behavioral Design Interventions to Address Stigma among Men Who have Sex with Men | NIH | National Institute of Mental Health | 2024 | $77,908 | February 8, 2025 | March 18, 2025 | BROMBERG, DANIEL J | reporter.nih.gov |
| Integrating spatial and non-spatial data to examine multilevel drivers of HIV risk among adolescent mothers in sub-Saharan Africa | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $74,268 | June 1, 2023 | May 31, 2025 | GEBREKRISTOS, LUWAM T | reporter.nih.gov |
| Aligning HIV services with gender diverse community priorities through person-centered care: a mixed methods study in India | NIH | National Institute of Mental Health | 2024 | $48,974 | June 1, 2024 | March 18, 2025 | KAPTCHUK, ROSE POLLARD | reporter.nih.gov |
| Effects of caregiver interactions, youth characteristics, and counseling on retention in care among youth living with HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $48,974 | December 16, 2024 | December 15, 2026 | HICKS, SARAH | reporter.nih.gov |
| HIV risk messaging and medical mistrust in the era of Undetectable=Untransmittable: Psychosocial and Behavioral Implications among Black, Latino/a/e/x, and Multiracial Sexual and Gender Minorities | NIH | National Institute of Mental Health | 2025 | $48,974 | January 7, 2025 | September 30, 2028 | KALWICZ, DAVID | reporter.nih.gov |
| Probing the Proteome: Depressive Symptoms, Inflammation and Mitochondrial Perturbations in Acute HIV Infection | NIH | National Institute of Mental Health | 2025 | $45,516 | December 15, 2024 | November 30, 2026 | CHAVEZ, JENNIFER VANESSA | reporter.nih.gov |
| Exploring Acceptability & Potential Reach of Game-Based & Social Network Strategies for Improving PrEP & HIV Self-Testing Uptake among Latinx Sexual Minority Men Living in an EHE Priority Jurisdiction | NIH | National Institute of Mental Health | 2024 | $42,749 | July 1, 2024 | March 19, 2025 | CRAKER, LACEY | reporter.nih.gov |
| Intersectional Discrimination and Sexual Health Among Young Black Men who Have Sex with Men: A Mixed Methods Study | NIH | National Institute of Mental Health | 2024 | $42,014 | July 1, 2024 | March 12, 2025 | JANEK, SARAH ELISE | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 225 | $253,190,730 | 0 | $0 |
| 2024 | 232 | $251,182,436 | 0 | $0 |
| 2023 | 137 | $250,865,002 | 0 | $0 |
| 2022 | 103 | $286,959,773 | 0 | $0 |
| 2021 | 75 | $104,170,345 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.